General MedicationsINJECTIONGeneric
VINORELBINE TARTRATE
VINORELBINE TARTRATE
Standard Dose
EQ 10MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview VINORELBINE TARTRATE is listed in Drugs@FDA under application 208997 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient VINORELBINE TARTRATE Form and strength INJECTABLE;INJECTION - EQ 10MG BASE/ML Sponsor NOVAST LABS Submission history Latest submission status date: 2020-08-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview VINORELBINE TARTRATE is listed in Drugs@FDA under application 208997 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient VINORELBINE TARTRATE Form and strength INJECTABLE;INJECTION - EQ 10MG BASE/ML Sponsor NOVAST LABS Submission history Latest submission status date: 2020-08-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.